Letter From Attorney General Lungren to Lann Lee RE: CHDP Program Letter #91-18
Correspondence
October 24, 1991
6 pages
Cite this item
-
Case Files, Matthews v. Kizer Hardbacks. Letter From Attorney General Lungren to Lann Lee RE: CHDP Program Letter #91-18, 1991. 1d6c3a77-5c40-f011-b4cb-7c1e5267c7b6. LDF Archives, Thurgood Marshall Institute. https://ldfrecollection.org/archives/archives-search/archives-item/a398884c-2124-4283-b5bd-21f7bb070c73/letter-from-attorney-general-lungren-to-lann-lee-re-chdp-program-letter-91-18. Accessed November 23, 2025.
Copied!
- *
DANIEL E. LUNGREN State of California
Attorney General DEPARTMENT OF JUSTICE
2101 WEBSTER STREET, 12th FLOOR
OAKLAND, CA 94612-3049
(510)464-4200
MAILING ADDRESS:
455 GOLDEN GATE AVENUE, SUITE 6200
SAN FRANCISCO, CA 94102-3658
(510) 464-1173
October 24, 1991
Bill Lann Lee
NAACP Legal Defense
and Educational Fund, Inc.
315 West Ninth Street, Suite 208
Los Angeles, California 90015
RE: Erika Matthews, et al. v. Molly Coye
U.S.D.C. Northern District No. C-90-3620 EFL
Dear Bill:
Pursuant to our telephone conversation of October 23, 1991
(as well as plain common sense) I am forwarding a copy of CHDP
Program Letter #91-18 which distributed Provider Information
Notice #91-10. Both documents are dated October 21, 1991.
As we discussed, please let us know who should be listed as
payee on the warrant for attorneys fees. The Department of
Health Services is moving expeditiously on this front too.
All best regards to you and your colleagues. It is always a
pleasure to deal with cooperative and competent professionals in
creating a result beneficial to all concerned.
Sincerely,
DANIEL E. LUNGREN
Attorney General
oid /
/ rl 7 / ir rT
(LR
HARLAN E. VAN WYE
Deputy Attorney General
HEV:lej
Enclosures
cc: Linda Slaughter (w/out encl.)
“a © oe
STATE OF CALIFORNIA—HEALTH AND WELFARE AGENCY PETE WILSON, Governor
DEPARTMENT OF HEALTH SERVICES
714/744 P STREET
P.O. BOX 942732
SACRAMENTO, CA 94234-7320
(916) 654-0364 October 21, 1991
CHDP Program Letter #91-18
To: Community Child Health and Disability Prevention (CHDP) Program
Directors and Deputy Directors
Subject: Provider Information Notice #91-10 Regarding Blood Lead Test
as a Part of Health Assessment for CHDP Eligible Children
Ages 6 Months to 72 Months
Attached is Provider Information Notice #91-10 informing providers of the need
71
assess all children from 6 months to 72 months of age for risk of lead
burden and do a blood lead test when determined to be at risk.
do blood lead testing on all children at one year of age.
do blood lead testing on any child under 72 months of age who has not
been tested. :
Distributing this notice is a condition of settling the law suit Mathews and
People United for a Better Oakland v. Coye and must be distributed without any
changes no later than October 30, 1991 to all your providers.
Return the “Notice of Distribution" by November 1, 1991 and include the date
sent to providers. If you have any questi , e contact your Regional
u (omy
don H. br 1 Ph.D. cree]
Child Health and Disability
Prevention Branch
Consultant.
STATE OF CALIFORNIA—HEALTH AND WELFARE AGENCY PETE WILSON. Governor
DEPARTMENT OF HEALTH SERVICES
714/744 P STREET
P.O. BOX 942732
SACRAMENTO, CA 94234-7320
(916) 657-1425 Jer Gtee 1, 1H
CHDP Provider Information Notice #91-10
To: CHDP Providers
Subject: Blood Lead Test as a Part of Health Assessment for CHDP Eligible
Children Ages 6 Months to 72 Months
In March of 1991, you received a letter from the Director of the Department of
Health Services which, in part, stated: "Lead poisoning is the most
significant environmental health problem facing California children today, and
insufficient consideration is being given this potential problem during
routine child health evaluations." The Department is acting on this concern
by expanding the blood lead testing/screening component of the health
assessment provided to Child Health and Disability Prevention (CHDP) Program
eligible children.
Effective November 20, all CHDP eligible children between 6 and 72 months are
to receive an evaluation for possible lead poisoning as part of each health
‘assessment. The evaluation shall include, at a minimum:
1. A blood lead test (Code #15) is to be administered to all CHDP program
eligible children at approximately one year of age, unless there is
reason that the test is medically contraindicated or the test is refused
by the parents.
2. Any child over one year of age, but less than 73 months, who has noc
been tested for. lead. poisoning is to also receive a blood lead test
(Code #15) during the child’s next subsequent periodic health assessment
unless there is reason that the test is medically contraindicated or the
test is refused by the parents.
3. A series of five (5) questions, intended to identify children at high
risk for lead poisoning, is to be directed to each child's
parent/guardian. The questions (See attached list) are to be asked ac
each periodic health assessment, beginning with the 6 month visit.
A child is considered low risk only if all five questions are answered
"No." If any child is determined to be high risk from initial or
subsequent questioning, a blood lead test (Code #15) is to be
administered immediately unless there is reason that the test is
medically contraindicated or the test is refused by che parents.
4 AC each subsequent periodic health assessment, Lf a child is determined
vs be high risk under paragraphs 1, 2, or 3 apove, a1 blood test
(Coda #15) is to be performed, unless thera is reason chat the rest is
medically contraindicated or rhe test is refused by the parcncs.
s A child is to be referred for appropriate diagnosis and/or treatment
when the results of tha blood leval test exceed 13 ug/dL. A child whose
blood lead test results are greater chan 10 ug/dL and less than 13 ug/dL
ig to be retasted at intervals consistent with the Qetober 1991 Canters
for Dissase Control statement enticled, Pravencing Lead Poisoning In
Young Children.
The reimbursement rates for the healch assessment and the blood lead test are
unchanged.
These changas {in the cesting/scrcening seococol are being made because of
reecant medical and scientific advancas. The concent of =his provider
information letter 1s intended to be consistent with these changes. The
Cancers for Disease Control scatement recommends a second universal test ac
about two vears of age if resources allow. The Department will keep you
informed of further davelopments and more derailad inscructions will follow,
Please feel free TO call your lecal CHDP program director if you nave any
questicns.
fLR..2
Molly Joel Cove, M.D. a2 A
Director
Attachment
Sr ——— ———— TT A i —
hs hl
Sl tg gpp— TT Lv —
ll
fra"
oo . re
CHILDHOOD LEAD POISONING EVALUATION QUESTIONNAIRE
The following questions are to be answered by the parents/guardians of CHDP
eligible children under 72 months of age at each periodic health assessment.
1. Does your child live in or regularly visit a house or other location
with peeling or chipping paint built before 1960? (This can include a
day care center, preschool, scheccl, barn, home of babysitter, relative,
friend, etc.)
Yes No
Does your child live in or regularly visit a house built before 1960
with recent or ongoing renovation or remodeling?
Yes No
Does your child have a parent, brother, sister, housemate or playmate
who is being treated or followed for lead poisoning (i.e., blood lead
> 10 ug/dL? a
Yes No
Does your child live with someone whose job or hobby involves exposure
to lead (i.e., painting, soldering, automobile battery manufacturing or
recycling, vehicle radiator repair)? :
Yes No
Does your child live near an active lead smelter or battery recycling
plant or other industry likely to release lead?
Yes No
o @
REPORT OF DISTRIBUTION
PROVIDER INFORMATION NOTICE #91-10
BLOOD LEAD TEST AS A PART OF HEALTH ASSESSMENT
FOR CHDP ELIGIBLE CHILDREN AGES 6 MONTHS TO 72 MONTHS
TO:
PROVIDER INFORMATION CLERK
CALIFORNIA STATE DEPARTMENT OF HEALTH SERVICES
CHILD HEALTH AND DISABILITY PREVENTION BRANCH
714 P STREET, ROOM 708
P.O. BOX 942732
SACRAMENTO, CA 94234-7320
THIS PROVIDER INFORMATION NOTICE WAS SENT TO PROVIDERS IN
COUNTY /COMMUNITY ON .
(DATE)
a,
.
SIGNATURE OF SENDER
PLEASE NOTE THAT NO CHANGE IS TO BE MADE IN THIS NOTICE OR ATTACHMENTS.
PLEASE COMPLETE THIS FORM AND FORWARD TO ADDRESS SHOWN ABOVE.
THANK YOU FOR YOUR COOPERATION.